GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ortin Global Ltd (NSE:ORTINGLOBE) » Definitions » Net Issuance of Preferred Stock

Ortin Global (NSE:ORTINGLOBE) Net Issuance of Preferred Stock : ₹0.00 Mil (TTM As of Sep. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Ortin Global Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Ortin Global's net issuance of preferred for the three months ended in Sep. 2024 was ₹0.00 Mil. The number is 0, which means that Ortin Global has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Ortin Global's net issuance of preferred for the trailing twelve months (TTM) ended in Sep. 2024 was ₹0.00 Mil.


Ortin Global Net Issuance of Preferred Stock Historical Data

The historical data trend for Ortin Global's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ortin Global Net Issuance of Preferred Stock Chart

Ortin Global Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Net Issuance of Preferred Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Ortin Global Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Net Issuance of Preferred Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Ortin Global Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ortin Global Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Ortin Global's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.


Ortin Global Business Description

Traded in Other Exchanges
Address
Road No.12, Mayfair Gardens, 8-2-682/3/A & 3B, Flat No. 201, 2nd Floor, Banjara Hills, Khairatabad, Hyderabad, TG, IND, 500034
Ortin Global Ltd is an Indian company engaged in the manufacturing and trading of Pharmaceuticals, Drugs, and Intermediates. Its formulations include anti-diabetics, anti-allergics, anti-anginal and cardiovascular, sedatives and tranquilisers, anti-helmenthetics, analgesics and antipyretics, antibiotics, antifungal, cephalosporins, and others. Some of its API intermediates include Ciprofloxacin, Tramadol, Efavarenz, Lamivudine, Zudavudine, Nevirapine, Lopinavir, Fluconazole, Triclabendazole, Omeprazole, and others. The company has two operating segments, including Manufacture and Trading. The company generates the majority of its revenue from the Trading division, which involves trading of Pharmaceuticals and medical Formulations.

Ortin Global Headlines

No Headlines